[Inadequate antidiuretic hormone secretion secondary to cyclophosphamide administration].
Juan
O
O
Solano
C
C
García-Conde
J
J
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy; D018270:Carcinoma, Ductal, Breast / Q000188:drug therapy; D003520:Cyclophosphamide / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007177:Inappropriate ADH Syndrome / Q000139:chemically induced*; D008875:Middle Aged
D003520:Cyclophosphamide
Síndrome de secreción inadecuada de hormona antidiurética secundarioa la administración de ciclofosfamida.